Overview
- EPA released a draft of its Sixth Contaminant Candidate List on Thursday that, for the first time, groups microplastics and pharmaceuticals as priorities and opens a 60-day public comment period ahead of a planned mid-November final list.
- HHS launched the $144 million STOMP program to map microplastics in people, build reliable detection tools, and explore ways to reduce or remove them, with ARPA-H saying it aims to develop a rapid, low-cost clinical test.
- EPA said it will publish human health benchmarks for 374 pharmaceuticals to guide monitoring and risk decisions, noting that these benchmarks are not enforceable standards.
- Scientists and policy experts caution that health risks from microplastics are still unclear and that labs lack consistent methods to sample, detect, and quantify particles across sizes, which makes comparisons and risk assessment difficult.
- The Contaminant Candidate List flags unregulated substances for research and possible future rules rather than setting limits now, so any new utility monitoring or national standards would come later through separate rulemaking.